
A SERS-based breathalyzer can distinguish volatile organic compounds in the breath of COVID-positive people in less than 5 minutes.
Credit: Shi Xuan Leong and Yong Xiang Leong, Nanyang Technological University
“Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 Min”
According to experts, bringing an end to the pandemic will require rapid screening of people attending large gatherings, such as conferences and weddings. Even those who are asymptomatic can still transmit COVID-19 to others, making it important to identify and isolate them until they are no longer contagious. Now, researchers reporting in ACS Nano have developed a prototype “breathalyzer” that can sensitively and accurately diagnose COVID-19, even in asymptomatic individuals, in less than 5 minutes.
Currently, the “gold standard” for COVID-19 testing is a technique called reverse transcription-polymerase chain reaction (RT-PCR), which is slow, requires an uncomfortable nasopharyngeal swab for sample collection and must be performed in a lab. The rapid antigen test is much quicker but has a higher rate of false negatives and positives. Scientists have also developed breathalyzer-type tests for COVID-19, which rely on differences in concentrations of volatile organic compounds exhaled by those infected with the coronavirus, but most require bulky, nonportable instruments for analysis. Xing Yi Ling and colleagues wanted to develop a quick, convenient and accurate breathalyzer test that would be suitable for on-site screening of large numbers of people.
The researchers designed a handheld breathalyzer that contains a chip with three surface-enhanced Raman scattering (SERS) sensors attached to silver nanocubes. When a person exhales into the device for 10 seconds, compounds in their breath chemically interact with the sensors. Then, the researchers load the breathalyzer into a portable Raman spectrometer that characterizes the bound compounds based on changes to the molecular vibrations of the SERS sensors.
The team found that Raman spectra from COVID-positive and -negative people were different in regions responsive to ketones, alcohols and aldehydes, which they used to develop a statistical model for COVID diagnosis. They tested the breathalyzer on 501 people in hospitals and airports in Singapore, who were shown by RT-PCR to be negative (85.2%), positive and symptomatic (8.6%), or positive and asymptomatic (6.2%) for the coronavirus. The method had a 3.8% false-negative and 0.1% false-positive rate, comparable to RT-PCR tests, but it could be completed on-site in less than 5 minutes. The breathalyzer could someday be a new tool to reduce the silent spread of COVID-19 in communities, the researchers say.
Original Article: Quick COVID breathalyzer could allow mass screening in public places
More from: Nanyang Technological University | National Centre for Infectious Diseases | University of Oxford | Mahidol University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID breathalyzer
- Is AI Impairment Testing Next for Cannabis?
The lack of a validated mechanism to test someone’s level of impairment from cannabis use on the spot has complicated the national rollout. Regulators and elected officials vent their fears about ...
- Global Point-Of-Care Breathalyzers Market | 2023-2030 | A Comprehensive Analysis with Data Solutions
Pages Report] Global “Point-Of-Care Breathalyzers Market” [2023-2030] latest research report with the latest facts ...
- The Mandatory In-Car Breathalyzer Is Only a Few Years Away
We may earn a commission from links on this page. There’s just one real problem: that piece of technology doesn’t really exist yet for a commercialized application. Because of this, the ...
- Global Point-of-Care Breathalyzer Market Size 2023 to 2026 Size and Share Survey Report
Mar 27, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Point-of-Care Breathalyzer ...
- Noze receives $1 million grant from Bill & Melinda Gates Foundation to build TB- and malaria-detecting breathalyzer
Montréal-based Noze has received a $1 million grant from the Bill & Melinda Gates Foundation to build a breathalyzer to detect infectious diseases.
Go deeper with Google Headlines on:
COVID breathalyzer
[google_news title=”” keyword=”COVID breathalyzer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Covid screening
- COVID-19 Pandemic - The government presents its daily update
1,661 health care workers absent for COVID-related reasons (preventive withdrawal ... Note that the number of cases listed is not representative of the situation since access to screening centres is ...
- OAE Screening System Market Outlook 2023 and Forecast to 2030 | Happersberger Otopront, Horentek, Resonance, Natus
The volatile COVID-19 pandemic has slashed revenues in a variety of industries around the world. It has wreaked havoc on the economy and resulted in unprecedented losses. Policymakers, business ...
- You may have skipped lung, colon, breast cancer screenings amid COVID. Time to fix that.
Daily COVID-19 cases in the U.S. from the BA ... they are upwards of two years behind in their critical disease screening appointments or have been unable to follow up as their primary care doctor ...
- Maharashtra Covid-19: State reports 425 new cases, active tally at 3,090
On the background of the international scenario of Covid-19, screening of international passengers arriving at Mumbai, Pune and Nagpur airports have been started from 24th Dec 2022. All passengers are ...
- Newborn Screening Market 2023 Growth, Trend and Outlook till 2031
The MarketWatch News Department was not involved in the creation of this content. Mar 30, 2023 (The Expresswire) -- Newborn Screening Marketinformation for each competitor includes (Agilent ...
Go deeper with Google Headlines on:
Covid screening
[google_news title=”” keyword=”covid screening” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]